Lexeo Therapeutics, Inc Common Stock
Price & Volume
Stats
See more52W Range | $2.25-$10.99 |
Market Cap | $472.6M |
Shares Short | 12M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$63.7M |
Diluted EPS | -$1.86 |
News
See moreYahoo Finance • 16 days ago
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
Yahoo Finance • 2 months ago
H.C. Wainwright Says Market Remains Unconvinced on Lexeo Therapeutics, Inc. (LXEO)’s PKP2 Program
Yahoo Finance • 4 months ago
Raymond James Sees an Attractive Setup in These 2 ‘Strong Buy’ Stocks
Yahoo Finance • 5 months ago
Lexeo Therapeutics Reports Third Quarter 2025 Financial Results and Operational Highlights
About
CEO | Mr. R. Nolan Townsend M.B.A. |
CFO | Mr. Louis Tamayo |
Address | 345 Park Avenue South, New York, NY, United States, 10010 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 59 |
